Jilin Aodong Pharmaceutical Group Co., Ltd.

XSEC:000623 Stock Report

Market Cap: CN¥21.9b

Jilin Aodong Pharmaceutical Group Future Growth

Future criteria checks 3/6

Jilin Aodong Pharmaceutical Group is forecast to grow earnings at 38.1% per annum. EPS is expected to grow by 36.7% per annum.

Key information

38.1%

Earnings growth rate

36.7%

EPS growth rate

Pharmaceuticals earnings growth18.9%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updated07 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:000623 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20243,0051,430-74306N/A
6/30/20243,278934-160333N/A
3/31/20243,5231,118-164286N/A
12/31/20233,4491,460-35168N/A
9/30/20233,3092,175-26494N/A
6/30/20233,2012,349-157101N/A
3/31/20233,0192,20735299N/A
1/1/20232,8681,781153424N/A
9/30/20222,618968-100171N/A
6/30/20222,4711,313-21692N/A
3/31/20222,4171,448-46262N/A
1/1/20222,3041,78112325N/A
9/30/20212,2341,898-55231N/A
6/30/20212,2131,65145324N/A
3/31/20212,3071,77225296N/A
12/31/20202,2521,709163390N/A
9/30/20202,3461,748318549N/A
6/30/20202,5671,552407600N/A
3/31/20202,7341,087275450N/A
12/31/20193,0881,404157379N/A
9/30/20193,2861,19934221N/A
6/30/20193,3861,19987275N/A
3/31/20193,4391,2550302N/A
12/31/20183,324935102348N/A
9/30/20183,3861,390184428N/A
6/30/20183,3321,560N/A371N/A
3/31/20183,1831,770N/A273N/A
12/31/20172,9771,863N/A256N/A
9/30/20172,8691,754N/A277N/A
6/30/20172,7451,739N/A281N/A
3/31/20172,6701,721N/A361N/A
12/31/20162,7371,666N/A334N/A
9/30/20162,5431,857N/A379N/A
6/30/20162,4131,772N/A416N/A
3/31/20162,3782,370N/A374N/A
12/31/20152,3352,594N/A388N/A
9/30/20152,2412,515N/A422N/A
6/30/20152,2442,530N/A315N/A
3/31/20152,2411,767N/A325N/A
12/31/20142,2401,411N/A289N/A
9/30/20142,2711,274N/A171N/A
6/30/20142,2271,175N/A267N/A
3/31/20142,0911,097N/A209N/A
12/31/20131,9571,059N/A201N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 000623's forecast earnings growth (38.1% per year) is above the savings rate (2.8%).

Earnings vs Market: 000623's earnings (38.1% per year) are forecast to grow faster than the CN market (26.1% per year).

High Growth Earnings: 000623's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 000623's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 000623's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 000623's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y